Results 221 to 230 of about 32,100 (296)

Traditional Chinese Medicine Combined With Chemotherapy for Mammary Paget's Disease With Multifocal Heterogeneous Breast Cancer: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
This flowchart systematically outlines the full diagnostic and therapeutic pathway of mammary Paget's disease with ipsilateral multifocal breast cancer, covering preoperative radiological assessment, postoperative histopathological confirmation of inter‐lesional molecular heterogeneity, individualized multimodal treatment, recurrence‐free follow‐up ...
Hongyu Cheng, Jiayin Tang, Chang Yao
wiley   +1 more source

First-line Anlotinib plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft-Tissue Sarcoma: A Phase II Single-Arm Trial. [PDF]

Clin Cancer Res
Zhao JK, Liu ZJ, Wang R, Fu H, Liu MY, Xu J, Xu X, Fan XC, Hu WY, Zhang H, Xu N, Hao T, Yuan HT, Zhang JB, Li MH, Zhou L, Yang CS, Wang XY, Zhu DY.   +18 more
europepmc   +1 more source

Successful Management and Treatment Rechallenge Following Docetaxel‐Induced Serpentine Supravenous Hyperpigmentation With Bullous Features: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Serpentine supravenous hyperpigmentation (SSH) is a rare dermatological complication of intravenous chemotherapy characterized by linear hyperpigmented streaks along superficial veins. Bullous SSH represents an exceptionally rare variant with only a few previously reported cases in the literature. We report the case of a 50‐year‐old woman with
Gayathri R. Nair, James Koutsis, Deepali Poels, Nita Agar, Sanjay Warrier, Sanjeev Kumar   +5 more
wiley   +1 more source

Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis. [PDF]

Cardiooncology
El-Helbawy A, Zaki ST, Hanna F, Bassiouni M, Yaseen KO, Ali AH, Farid OM.   +6 more
europepmc   +1 more source

Intensive Induction in AML in the Era of Venetoclax: A Standing Count for “7 + 3”?

American Journal of Hematology, Volume 101, Issue 8, Page 1783-1789, August 2026.
Sudhir Tauro, Ayalew Tefferi
wiley   +1 more source

Acute and Chronic Leukemia in Sub‐Saharan Africa: A Systematic Review

Cancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background The four primary subgroups of leukemia include chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). Very little is known about the regional variation of leukemia and subtypes in sub‐Saharan Africa (SSA).
Allwell A. Ayirebi, Stephen Twumasi, Linda K. Olaga, Benedict Sackey, Daniel N. M. Antonio, Richard O. Ansah, Eugene A. Ansah, John A. Sah, Enoch O. Anto, Yvonne Anang‐Quartey, Antoinette Koomson, Angela Opoku, Godfred A. Donkor, Paulina Duah, Ama G. Boadu, Samuel Essien‐Baidoo, Wina I. O. Boadu, Lilian A. Boateng   +17 more
wiley   +1 more source

Major Adverse Cardiovascular Events and Cardiac Dysfunction in Patients With Acute Leukemia: A Prospective Study. [PDF]

JACC CardioOncol
Kang Y, Lefebvre B, Smith A, Koropeckyj-Cox D, Brahmbhatt P, Ky B, Carver J, McCurdy S, Luger S, Scherrer-Crosbie M.   +9 more
europepmc   +1 more source

Improvement in Outcomes of Childhood Acute Myeloid Leukemia Treatment: A Survival Analysis at a Reference University Hospital in Rio de Janeiro, Brazil

Cancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Acute myeloid leukemia (AML) represents 15% to 20% of all pediatric acute leukemias and is responsible for nearly 30% of deaths in this population. While high‐income countries report overall survival (OS) rates near 75%, survival in Brazil remains significantly lower, ranging between 30% and 40%.
Thais Alcantara Bonilha, Deborah Sutter Ayres Pereira, Alice Maria Boulhosa de Azevedo, Adriana Martins de Sousa, Elaine Sobral da Costa, Marcelo Gerardin Poirot Land   +5 more
wiley   +1 more source

Identification and Validation of Metabolic Hub Genes Using WGCNA and Prognostic Risk Modeling in Acute Myeloid Leukemia

Cancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Acute myeloid leukemia (AML) is an aggressive and molecularly heterogeneous hematologic malignancy associated with poor clinical outcomes, particularly in elderly and high‐risk patients. Increasing evidence suggests that metabolic reprogramming plays a critical role in leukemia progression, immune dysregulation, and therapeutic ...
Samaneh Ramezani, Fatemeh Akhoundi, Reza Valadan, Hossein Asgarian‐Omran   +3 more
wiley   +1 more source

Pediatric Cardio-Oncology: From Gap in Evidence to Future Perspectives. [PDF]

Diagnostics (Basel)
Correra A, Cetoretta V, Maratea AC, Ferrara S, Di Sarno I, Russo V, Guerra F, Mauriello A, D'Andrea A.   +8 more
europepmc   +1 more source